1. 13 Efficacy on individualized starting dose (ISD) and fixed starting dose (FSD) of niraparib per investigator-assessment (IA) in newly diagnosed advanced ovarian cancer (OC). (13th November 2020) Authors: Graybill, W; Mirza, M; González-Martin, A; O'Malley, D; Gaba, L; Yap, OWS; Guerra, E; Rose, PG; Baurain, J; Ghamande, S; Denys, H; Prendergast, E; Pisano, C; Follana, P; Braicu, EI; Calvert, PM; Korach, J; Li, Y; Gupta, D; Monk, BJ Journal: International journal of gynecological cancer Issue: Volume 30(2020)Supplement 3 Page Start: A10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 17 Safety and patient-reported outcomes in patients receiving niraparib in the PRIMA/ENGOT-OV26/GOG-3012 trial. (13th November 2020) Authors: Freyer, G; Pothuri, B; Han, S; Chase, D; Monk, B; Heitz, F; Burger, R; Gaba, L; Van Le, L; Guerra, E; Bender, D; Korach, J; Cloven, N; Churruca, C; Follana, P; DiSilvestro, P; Baurain, JF; Jardon, K; Pisano, C; Peen, U Journal: International journal of gynecological cancer Issue: Volume 30(2020)Supplement 3 Page Start: A12 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Carboplatin-based doublet plus bevacizumab beyond progression versus carboplatin-based doublet alone in patients with platinum-sensitive ovarian cancer: a randomised, phase 3 trial. Issue 2 (February 2021) Authors: Pignata, Sandro; Lorusso, Domenica; Joly, Florence; Gallo, Ciro; Colombo, Nicoletta; Sessa, Cristiana; Bamias, Aristotelis; Salutari, Vanda; Selle, Frédèric; Frezzini, Simona; De Giorgi, Ugo; Pautier, Patricia; Bologna, Alessandra; Orditura, Michele; Dubot, Coraline; Gadducci, Angiolo; Mammoliti,... Journal: Lancet oncology Issue: Volume 22:Issue 2(2021) Page Start: 267 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Quality-of-life analysis of the MITO-8, MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG study comparing platinum-based versus non-platinum-based chemotherapy in patients with partially platinum-sensitive recurrent ovarian cancer. (16th February 2018) Authors: Piccirillo, M C; Scambia, G; Bologna, A; Signoriello, S; Vergote, I; Baumann, K; Lorusso, D; Murgia, V; Sorio, R; Ferrandina, G; Sacco, C; Cormio, G; Breda, E; Cinieri, S; Natale, D; Mangili, G; Pisano, C; Cecere, S C; Di Napoli, M; Salutari, V Journal: Annals of oncology Issue: Volume 29:Number 5(2018) Page Start: 1189 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗